Fulgent Genetics Inc logo

Fulgent Genetics Inc

6
5
NAS:FLGT (USA)  
$ 23.40 -2.075 (-8.14%) 10:09 PM EST
At Loss
P/B:
0.61
Market Cap:
$ 755.35M
Enterprise V:
$ 290.44M
Volume:
837.97K
Avg Vol (2M):
165.24K
Also Trade In:
Volume:
837.97K
At Loss
Avg Vol (2M):
165.24K

Business Description

Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Name Current Vs Industry Vs History
Cash-To-Debt 161.87
Equity-to-Asset 0.93
Debt-to-EBITDA -0.06
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.74
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.4
9-Day RSI 35.83
14-Day RSI 37.78
6-1 Month Momentum % -23.81
12-1 Month Momentum % -21.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.95
Quick Ratio 8.87
Cash Ratio 7.62
Days Inventory 10.12
Days Sales Outstanding 72.52
Days Payable 36.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.1
Shareholder Yield % 5.26

Financials (Next Earnings Date:2024-02-28)

FLGT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FLGT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Fulgent Genetics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 286.412
EPS (TTM) ($) -2.14
Beta 1.1
Volatility % 51.77
14-Day RSI 37.78
14-Day ATR ($) 0.956386
20-Day SMA ($) 25.006
12-1 Month Momentum % -21.93
52-Week Range ($) 23.09 - 44.09
Shares Outstanding (Mil) 29.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fulgent Genetics Inc Filings

Filing Date Document Date Form
No Filing Data

Fulgent Genetics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Fulgent Genetics Inc Frequently Asked Questions

What is Fulgent Genetics Inc(FLGT)'s stock price today?
The current price of FLGT is $23.40. The 52 week high of FLGT is $44.09 and 52 week low is $23.09.
When is next earnings date of Fulgent Genetics Inc(FLGT)?
The next earnings date of Fulgent Genetics Inc(FLGT) is 2024-02-28.
Does Fulgent Genetics Inc(FLGT) pay dividends? If so, how much?
Fulgent Genetics Inc(FLGT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1